The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: A population-based study in greater Amsterdam

Journal of Surgical Oncology

Volumn 95, Issue 6, 2007, Pages 447-454

  Visser, O ^a   Bakx, R ^b   Zoetmulder, F A N ^c   Levering, C C ^a   Meijer, S ^d   Slors, J F M ^b   Van Lanschot, J J B ^b  

^a Integraal Kankercentrum Amsterdam   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Rectal carcinoma; Recurrent disease; Relative survival; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RECTUM CANCER; RECTUM RESECTION; RETROSPECTIVE STUDY; SURVIVAL TIME;

AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NETHERLANDS; PROGNOSIS; RECTAL NEOPLASMS; RECTUM; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VITAL STATISTICS;

EID: 34248149562     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20713     Document Type: Article

References (29)

1. Landis SH, Murray T, Bolden S, et al.: Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. Visser O, Siesling S, Van Dijck JA, editors: Incidence of Cancer in the Netherlands 1999/2000. Utrecht: Vereniging van Integrale Kankercentra, 2003.
3. Ferlay J, Bray B, Pisani P, et al., editors: GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase No. 5. Lyon: IARC Press, 2001.
4. Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg 1996;83:293-304.
5. Kapiteijn E, Marijnen CA, Colenbrander AC, et al.: Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: A population-based study in the west Netherlands. Eur J Surg Oncol 1998;24:528-535.
6. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479-1482.
7. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-460.
8. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
9. Glimelius B, Gronberg H, Jarhult J, et al.: A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003;42:476-492.
10. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-987.
11. Sobin LH, Wittekind CH, editors: International Union Against Cancer (UICC). TNM classification of malignant tumours. 6th ed. New York: Willey and sons, 2002.
12. Visser O, van Leeuwen FE: Stage specific survival of epithelial cancers in North-Holland/Flevoland, The Netherlands. Eur J Cancer 2005;41:2321-2330.
13. Dickman P, Sloggett A, Hills M: Life table estimates of relative survival. www.pauldickman.com (last accessed February 2006).
14. Cox DR: Regression models and life-table. J R Stat Soc 1972;34:187-220.
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
16. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, et al.: No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001;19:1976-1984.
17. Mollen R, Damhuis R, Coebergh J. Local recurrence and survival in patients with rectal cancer, diagnosed 1981-86: A community hospital-based study in the south-east Netherlands. Eur J Surg Oncol 1997;23:20-23.
18. Manfredi S, Benhamiche A, Meny B, et al.: Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal caner. Br J Surg 2001;88:1221-1227.
19. Cedermark B, Johansson H, Rutqvist LE, et al.: The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995;75:2269-2275.
20. Martling A, Holm T, Johansson H, et al.: The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: Long-term follow-up of a population-based study. Cancer 2001;92:896-902.
21. Marijnen CA, Peeters KC, Putter H, et al.: Long term results, toxicity and quality of life in the TME trial. Abstract 166, 2005 Gastrointestinal Cancers Symposium, Hollywood (http://www. asco.org/ac/1,1003,_12-002627-00_18- 0036-00_ 19-0010346,00. asp) (last accessed: February 2006).
22. Bakx R, van Tinteren H, van Lanschot JJ, et al.: Surgical treatment of locally recurrent rectal cancer. Eur J Surg Oncol 2004;30:857-863.
23. Sant M, Aareleid T, Berrino F, et al.: EUROCARE-3: Survival of cancer patients diagnosed 1990-94 - Results and commentary. Ann Oncol 2003;14:v61-118.
24. Semmens J, Platell C, Threlfall T, et al.: A population-based study of the incidence, mortality and outcomes in patients following surgery for colorectal cancer in Western Australia. Aust NZ J Surg 2000;70:11-18.
25. Yeole B, Sunny L, Swaminathan R, et al.: Population-based survival from colorectal cancer in Mumbai (Bombay) India. Eur J Cancer 2001;37:1402-1408.
26. Graupera Boschmonar M, Jiménez Chaviano P, Martín García A, et al.: Trends in survival rates of cancer in Cuba. Eur J Epidemiol 1999;15:521-528.
27. Gloeckler Ries L, Reichman M, Lewis D, et al.: Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. The Oncologist 2003;8:541-552.
28. Martling A, Holm T, Rutqvist L, et al.: Impact of a surgical training program on rectal cancer outcomes in Stockholm. Br J Surg 2005;92:225-229.
29. Kapiteijn E, Putter H, Van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002; 89:1142-1149.